These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 1854464)
61. An inpatient trial of the safety and efficacy of losartan compared with placebo and enalapril in patients with essential hypertension. Byyny RL; Merrill DD; Bradstreet TE; Sweet CS Cardiovasc Drugs Ther; 1996 Jul; 10(3):313-9. PubMed ID: 8877074 [TBL] [Abstract][Full Text] [Related]
62. Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension. Goa KL; Wagstaff AJ Drugs; 1996 May; 51(5):820-45. PubMed ID: 8861549 [TBL] [Abstract][Full Text] [Related]
63. Effects of the angiotensin type I receptor antagonist, losartan, on systemic and regional vascular responses to lower body negative pressure in healthy volunteers. Duranteau J; Pussard E; Berdeaux A; Giudicelli JF Br J Clin Pharmacol; 1995 Nov; 40(5):431-8. PubMed ID: 8703646 [TBL] [Abstract][Full Text] [Related]
64. Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans. Ohtawa M; Takayama F; Saitoh K; Yoshinaga T; Nakashima M Br J Clin Pharmacol; 1993 Mar; 35(3):290-7. PubMed ID: 8471405 [TBL] [Abstract][Full Text] [Related]
65. Angiotensin II receptor blockade with single doses of valsartan in healthy, normotensive subjects. Müller P; Cohen T; de Gasparo M; Sioufi A; Racine-Poon A; Howald H Eur J Clin Pharmacol; 1994; 47(3):231-45. PubMed ID: 7867676 [TBL] [Abstract][Full Text] [Related]
66. Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II. Christen Y; Waeber B; Nussberger J; Porchet M; Borland RM; Lee RJ; Maggon K; Shum L; Timmermans PB; Brunner HR Circulation; 1991 Apr; 83(4):1333-42. PubMed ID: 2013151 [TBL] [Abstract][Full Text] [Related]
67. Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist. Munafo A; Christen Y; Nussberger J; Shum LY; Borland RM; Lee RJ; Waeber B; Biollaz J; Brunner HR Clin Pharmacol Ther; 1992 May; 51(5):513-21. PubMed ID: 1587065 [TBL] [Abstract][Full Text] [Related]
68. Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers. Goldberg MR; Tanaka W; Barchowsky A; Bradstreet TE; McCrea J; Lo MW; McWilliams EJ; Bjornsson TD Hypertension; 1993 May; 21(5):704-13. PubMed ID: 8491505 [TBL] [Abstract][Full Text] [Related]
69. Effects of the angiotensin II receptor antagonist Losartan (DuP 753/MK 954) on arterial blood pressure, heart rate, plasma concentrations of angiotensin II and renin and the pressor response to infused angiotensin II in the salt-deplete dog. MacFadyen RJ; Tree M; Lever AF; Reid JL Clin Sci (Lond); 1992 Nov; 83(5):549-56. PubMed ID: 1335390 [TBL] [Abstract][Full Text] [Related]
70. Dose-response relationships following oral administration of DuP 753 to normal humans. Christen Y; Waeber B; Nussberger J; Lee RJ; Timmermans PB; Brunner HR Am J Hypertens; 1991 Apr; 4(4 Pt 2):350S-353S. PubMed ID: 1854464 [TBL] [Abstract][Full Text] [Related]
71. In vivo pharmacology of DuP 753. Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB Am J Hypertens; 1991 Apr; 4(4 Pt 2):288S-298S. PubMed ID: 1854454 [TBL] [Abstract][Full Text] [Related]